

NCT00846703 comparison:

Summary:
CHIA has 22 criteria while your personal folder has 22 criteria
Total found criteria: 22/22
Total not Found: 0/22
Total Extra: 3
This trial is VALID



╒═══════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                     │ Matching Personal Criteria                         │
╞═══════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Cytologically proven acute lymphoblastic leukemia │ Cytologically proven acute lymphoblastic leukemia  │
│ (ALL)                                             │ (ALL)                                              │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ No relapse of a previously unrecognized ALL       │ No relapse of a previously unrecognized ALL        │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients must meet one of the following risk      │ Patients must meet one of the following risk       │
│ criteria                                          │ criteria                                           │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Standard-risk (SR) group meeting all of the       │ Standard-risk (SR) group meeting all of the        │
│ following criteria                                │ following criteria                                 │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Blasts < 1,000/µL in peripheral blood (PB) on day │ Blasts \< 1,000/μL in peripheral blood (PB) on day │
│ 8                                                 │ 8                                                  │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Aged 1 to < 6 years                               │ Aged 1 to \< 6 years                               │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Initial WBC < 20,000/µL                           │ Initial WBC \< 20,000/μL                           │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ M1 (5%) or M2 (= 5% to < 25%) blasts in bone      │ M1 (5%) or M2 (≥ 5% to \< 25%) blasts in bone      │
│ marrow on day 15                                  │ marrow on day 15                                   │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ M1 marrow on day 33                               │ M1 marrow on day 33                                │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Aged < 1 or = 6 years and/or WBC = 20,000/µL      │ Aged \< 1 or ≥ 6 years and/or WBC ≥ 20,000/μL      │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Blasts < 1,000/µL in PB on day 8                  │ Blasts \< 1,000/μL in PB on day 8                  │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ M1 or M2 marrow on day 15                         │ M1 or M2 marrow on day 15                          │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ M3 (= 25%) marrow on day 15 OR meets SR criteria  │ M3 (≥ 25%) marrow on day 15 OR meets SR criteria   │
│ but M3 marrow on day 15 and *M1 marrow on day 33  │ but M3 marrow on day 15 and \*M1 marrow on day 33  │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Meets IR criteria and M3 marrow on day 15 (not SR │ Meets IR criteria and M3 marrow on day 15 (not SR  │
│ and M3 on day 15)                                 │ and M3 on day 15)                                  │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Blasts = 1,000/µL in PB on day 8                  │ Blasts ≥ 1,000/μL in PB on day 8                   │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ M2 or M3 marrow on day 33                         │ M2 or M3 marrow on day 33                          │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Translocation t(9;22) [BCR/ABL+] (Philadelphia    │ Translocation t(9;22) \[BCR/ABL+\] (Philadelphia   │
│ chromosome-positive) or t(4;11) [MLL/AF4+]        │ chromosome-positive) or t(4;11) \[MLL/AF4+\]       │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ No Down syndrome                                  │ No Down syndrome                                   │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ No other major disease that prohibits study       │ No other major disease that prohibits study        │
│ treatment (e.g., severe congenital heart disease) │ treatment (e.g., severe congenital heart disease)  │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Not requiring significant therapy modification    │ Not requiring significant therapy modification     │
│ owing to study therapy associated complications   │ owing to study therapy associated complications    │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ No complications due to other interventions       │ No complications due to other interventions        │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ No one with missing data that are needed for the  │ No one with missing data that are needed for the   │
│ differential diagnosis, or for selection of the   │ differential diagnosis, or for selection of the    │
│ proper therapy arm                                │ proper therapy arm                                 │
╘═══════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                            │
╞════════════════════════════════════════════════════════════════════╡
│ Must have maximum age of 16 Years                                  │
├────────────────────────────────────────────────────────────────────┤
│ High-risk (HR) group meeting ≥ 1 of the following criteria         │
├────────────────────────────────────────────────────────────────────┤
│ Intermediate-risk (IR) group meeting all of the following criteria │
╘════════════════════════════════════════════════════════════════════╛